Literature DB >> 218012

Deoxymorphines: role of the phenolic hydroxyl in antinociception and opiate receptor interactions.

J Reden, M F Reich, K C Rice, A E Jacobson, A Brossi, R A Streaty, W A Klee.   

Abstract

Several 3-deoxy opioids and 3,6-dideoxydihydromorphine was synthesized to ascertain the effect of the phenolic hydroxyl group on antinociceptive potency and receptor binding affinity. Catalytic reduction of the 3-tetrazolyl ether derivatives of dihydromorphine provided the entry into the 3-deoxydihydro series. The prototype, 3-deoxymorphine, was prepared by lithium aluminum hydride reduction of 3-deoxy-N-carbethoxymorphinone, obtained via its 7-(phenylseleno) derivative. 3-Deoxydihydromorphinone and 3,6-dideoxydihydromorphine were found to be about as potent as, or more potent than, morphine in standard antiociceptive assays. Each of them, however, was less potent than the comparable 3-hydroxy analogue, and their binding affinity to the opiate receptor was substantially decreased. The epoxy ring in 3.6-dideoxydihydromorphine was found to increase the antinociceptive potency of the compound.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 218012     DOI: 10.1021/jm00189a007

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  6 in total

1.  Synthesis, binding affinity, and functional in vitro activity of 3-benzylaminomorphinan and 3-benzylaminomorphine ligands at opioid receptors.

Authors:  John L Neumeyer; Bin Zhang; Tangzhi Zhang; Anna W Sromek; Brian I Knapp; Dana J Cohen; Jean M Bidlack
Journal:  J Med Chem       Date:  2012-04-04       Impact factor: 7.446

2.  Synthesis and immunological effects of heroin vaccines.

Authors:  Fuying Li; Kejun Cheng; Joshua F G Antoline; Malliga R Iyer; Gary R Matyas; Oscar B Torres; Rashmi Jalah; Zoltan Beck; Carl R Alving; Damon A Parrish; Jeffrey R Deschamps; Arthur E Jacobson; Kenner C Rice
Journal:  Org Biomol Chem       Date:  2014-10-07       Impact factor: 3.876

3.  Synthesis and opioid receptor binding affinities of 2-substituted and 3-aminomorphinans: ligands for mu, kappa, and delta opioid receptors.

Authors:  Michael Decker; Yu-Gui Si; Brian I Knapp; Jean M Bidlack; John L Neumeyer
Journal:  J Med Chem       Date:  2010-01-14       Impact factor: 7.446

4.  A pseudoreceptor docking study of 4,5-alpha-epoxymorphinans with a range of dielectric constants.

Authors:  R Gussio; S Pou; J H Chen; G W Smythers
Journal:  J Comput Aided Mol Des       Date:  1992-04       Impact factor: 3.686

5.  Evaluation of the P-glycoprotein (Abcb1) affinity status of a series of morphine analogs: comparative study with meperidine analogs to identify opioids with minimal P-glycoprotein interactions.

Authors:  Hazem E Hassan; Susan L Mercer; Christopher W Cunningham; Andrew Coop; Natalie D Eddington
Journal:  Int J Pharm       Date:  2009-04-05       Impact factor: 5.875

6.  Opioids and efflux transporters. Part 2: P-glycoprotein substrate activity of 3- and 6-substituted morphine analogs.

Authors:  Christopher W Cunningham; Susan L Mercer; Hazem E Hassan; John R Traynor; Natalie D Eddington; Andrew Coop
Journal:  J Med Chem       Date:  2008-02-27       Impact factor: 7.446

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.